Bull & Lifshitz, LLP Announces Investigation of the Acquisition of Trubion Pharmaceuticals, Inc.
16 Août 2010 - 7:38PM
Business Wire
Bull & Lifshitz, LLP announces an investigation into
possible breaches of fiduciary duty in connection with the proposed
acquisition of Trubion Pharmaceuticals, Inc. (NASDAQ: TRBN)
(referred to as "Trubion" or the “Company”) by Emergent
BioSolutions Inc. (referred to as “Emergent BioSolutions”) in a
transaction valued at approximately $135.5 million.
Under the terms of the merger agreement, each share of Trubion
common stock will be converted into the right to receive an upfront
payment of $1.365 per share in cash and 0.1641 shares of Emergent
BioSolutions common stock. The upfront payment represents a value
of $4.55 per share, or approximately $96.8 million based on
Trubion's total common shares outstanding, the net value of
dilutive stock options, and the trading average of Emergent
BioSolutions common stock for the five days prior to the signing of
the definitive agreement. Trubion stockholders will also receive
one Contingent Value Right (CVR) per share. The total potential
aggregate value of the CVRs is $38.7 million over a 36-month
period, post-closing.
Bull & Lifshitz, LLP's investigation is focused on whether
the proposed deal provides adequate value to the Company’s
shareholders.
If you are a holder of Trubion stock and want to discuss your
legal rights, you contact Bull & Lifshitz, LLP who will,
without obligation or cost to you, attempt to answer your
questions.
If you are a shareholder of Trubion and would like more
information about our investigation, please contact Joshua M.
Lifshitz, Esq. by telephone at (866) 313-6222 or by sending an
e-mail including your contact information to:
counsel@nyclasslaw.com. All e-mail correspondence should make
reference to Trubion.
Bull & Lifshitz, LLP is a New York City-based law firm with
significant experience representing investors in merger-related
shareholder class actions, shareholder derivative actions, and
securities fraud class actions. For more information about the
firm, please visit our website at www.nyclasslaw.com.
ATTORNEY ADVERTISING. © 2010 Bull & Lifshitz, LLP.
The law firm responsible for this advertisement is Bull &
Lifshitz, LLP, 18 East 41st Street, New York, New York 10017, (212)
213-6222. Prior results do not guarantee or predict a similar
outcome with respect to any future matter.
Trubion Pharmaceuticals (MM) (NASDAQ:TRBN)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Trubion Pharmaceuticals (MM) (NASDAQ:TRBN)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024